Nasopharyngeal carcinoma (NPC), an epithelial malignancy characterized by marked geographic and population differences in incidence, exemplifies the association of a human solid tumor with viral infection (11) . The EpsteinBarr virus (EBV), a ubiquitous lymphotrophic herpesvirus, is consistently detected in NPC, suggesting that EBV infection is critically involved in the induction of this malignancy (10, 34) .
Structural analyses of the EBV genome have revealed that the circular intracellular form of the EBV genome can be distinguished from the linear virion form by identification of the restriction enzyme fragment representing the fused termini (33) . The terminal restriction enzyme fragments of EBV are heterogeneous in size because of various numbers of copies of the terminal repeat (22, 27) . In agarose gel electrophoresis, the terminal fragments of the linear genomes migrate as ladder arrays of fragments. However, in NPC a single restriction enzyme fragment representing the fused termini of the EBV genome is detected (33) . The clonality of the viral genomes in NPC suggests, by extension, cellular clonality. The unique ability to assess cellular clonality in this epithelial malignancy makes NPC one of the few carcinomas which is known to be clonal.
The occurrence of NPC at high incidence in discrete genetic populations and in specific areas of endemicity suggests that genetic or environmental cofactors also contribute to the development of NPC. The genetic alterations that contribute to the emergence of a malignant clone from the multiple cells which may be infected by EBV are as yet unknown. Many genes which contribute to malignant progression have been identified cytogenetically. However, cytogenetic studies with NPC are limited because of the difficulties in culturing NPC tissue in vitro (26, 42) . Abnormal cellular DNA content, possibly reflecting aneuploidy, * Corresponding author.
was detected in 60% of a large number of pretreatment NPC specimens by using flow cytometry (7) . Karyotypic analysis of two epithelial cell lines established from NPC tissue and of the rare NPC samples that can be established in nude mice revealed aneuploidy, but a consistent chromosomal marker was not identified (26, 46, 47 (2, 31, 40) .
NPC is a unique epithelial malignancy in that it develops in discrete genetic populations and geographic pockets, yet it is consistently associated with a single, ubiquitous infectious agent, EBV (10, 11, 34) . To date, the role of alterations in 
MATERIALS AND METHODS
Tissues and cell lines. Primary and metastatic NPC obtained at biopsy were preserved at -70°C. The frozen tissues were pulverized and dissolved in 4 M guanidine thiocyanate, and the DNA fractions were extracted twice with phenol and chloroform after dialysis and proteinase K treatment (35) . The xenografts passaged in nude mice have been previously characterized and shown to be EBV positive (5, 26, 35) . C15 and 2117 were established from primary biopsy material, whereas C17, C18, and C19 were established from metastatic tumors. The CNE-1 and CNE-2 epithelial cell lines, which were established from NPC and can be passaged in nude mice, became EBV negative during culture (46, 47 PCR sequencing. Five to 10% of the preamplified and purified 2.9-kb fragments of the p53 gene were subjected to a second asymmetric PCR reaction with primer pairs P3 and P4 (exon 5), P5 and P6 (exon 6), P7 and P8 (exon 7), and P9 and P10 (exon 8) (Table 1 ) (4). The concentrations of the primers were 0.5 and 0.01 ,uM, respectively, for the first and second primer of each pair. Both strands were sequenced for each exon. The respective primers were then used to prime the sequencing reactions.
The product of the asymmetric PCR was purified and dissolved in 15 RI of water. An aliquot (7.5 ,ul) was taken for each sequencing reaction. The commercially available Sequenase kit was used for sequencing (United States Biochemical Sequence, Cleveland, Ohio). After electrophoresis on 8% polyacrylamide-5 M urea gels (2 h at 55 W) and drying, the gel was exposed to Kodak XAR film overnight. Differential PCR. Differential PCR was essentially performed as previously described (30) . The primer sequences of the reference genes, beta and gamma interferon, employed in the differential PCR have been published (18, 30) . Amplification of sequences in exons 5, 7, and 8 of the p53 gene was performed in conjunction with amplification of single-copy 150-and 170-bp sequences within the beta and gamma interferon genes, respectively. After electrophoresis and ethidium bromide staining of the PCR products, the degree of amplification was determined by densitometric analysis of the negatives obtained.
RESULTS
Restriction enzyme analysis of p53 in NPC. To determine if structural alterations in the p53 gene could be detected by restriction enzyme analysis, total DNA extracted from NPC specimens was digested with EcoRI and hybridized to a single-stranded RNA probe synthesized from a p53 cDNA ( Fig. 1) (Table  2) .
In 38 of 40 NPC samples the 2.9-kb fragment of p53 was successfully amplified (Table 2 ). In two epithelial cell lines derived from NPC, CNE-1 and CNE-2, which have been passaged in nude mice, the 2.9-kb fragment was also successfully amplified (46, 47) . However, the 2.9-kb fragment could not be amplified from DNA from the C17 and C19 NPC tumors, suggesting the presence of deletions.
NPC specimens obtained at biopsy have infiltrating lymphocytes and may contain normal tissue. Therefore, to determine that the hybridization signal and the amplification of the 2.9-kb fragment represented the tumor tissue, a modification of PCR, DPCR, was developed to analyze the NPC specimens for deletions of exons 5, 7, and 8. DPCR has been successfully used for the detection of allelic loss at the beta interferon locus in chronic myelogenous leukemia (30) . Amplification of exons 5, 7, and 8 and either beta or gamma interferon as an internal control is presented in Fig. 2 . DNA prepared from C15 was amplified successfully and shown by sequence analysis to be normal. This DNA was compared with that in C17 and C19, in which the initial amplification of the 2.9-kb fragment had failed. The three exons could be amplified in C15, whereas in C17 only the reference marker, gamma interferon, could be detected. In C19, exons 7 and 8 were amplified but exon 5 could not be detected (Fig. 2A) . Amplification of exon 5 or 7 alone compared with amplification of beta interferon confirmed deletion of exons 5 and 7 in C17 and deletion of exon 5 in C19 (Fig. 2B and C) . In contrast, exons 5, 7, and 8 were amplified at equivalent levels to the interferon reference markers in the NPC specimens indicated in Table 2 .
These data indicate the loss of the p53 coding sequences in C17 and confirm the complete absence of hybridization in C17 in the Southern blot analyses. In C19, the restriction enzyme fragment appeared to be slightly smaller than the 15-kb normal fragment. This would result from the deletion of sequences 5' to exon 5 through the first amplimer, P1.
Detection of p53 mutations by SSCP analysis. Since point mutation can significantly perturb p53 function, the prevalence of p53 mutation was analyzed in the NPC samples. SSCP analysis (32) was employed to screen DNA samples for changes in exons 5, 6, 7, and 8 in p53, where mutational hot spots exist. The basis of this technique is that radiolabeled PCR products when denatured and allowed to renature in dilute conditions will assume an intramolecular secondary structure unique to that sequence. This approach has been successfully utilized for the detection of point mutations in the ras gene family and the neurofibromatosis type 1 gene (6, 32) .
In this study, SSCP analysis was performed by the amplification of the individual exons 5, 6, 7, and 8 by using the 2.9-kb PCR fragment as a template. The amplified fragments representing specific exons were subsequently subjected to nondenaturing gel electrophoresis. To Fig. 3A) . In this analysis, normal migration was observed in DNA from normal blood and the C15 tumor. Sequence analysis of exon 5 revealed that N18 had the same deletion of the C residue in codon 138 without a detectable normal allele (Table 3 ; Fig.  3B ).
Another type of mutation in exon S was detected in C18, a nude mouse-passaged tumor. As shown in Fig. 4A , normal migration was detected in DNA from four specimens of NPC, including metastatic and primary tumors, in comparison with an apparent mutation in C18 and the absence of a normal allele. Sequence analysis of C18 revealed a duplication of codons 149 to 153 (Table 3 ; Fig. 4B ).
Abnormal migration in both exon 6 and 7 was detected in a single specimen, NM6, and NPC passaged in nude mice (35) (Fig. 5 and 6 ). The abnormal migration for exon 6 in NM6 and in an NPC metastasis, AlL, is compared with normal migration in a primary NPC and a posttransplant lymphoma (Fig. SA) . The altered migration in exon 7 in NM6 is compared with normal migration in a second NPC xenograft, NM1, one primary NPC, and three metastatic NPC (Fig. 6A) . Sequence analysis of the NPC, AlL, revealed a nonsense mutation in exon 6 converting a CGA to a termination codon TGA. The sequence of NM6 indicated multiple mutations in codons 210 through 215 in exon 6 and a transition of G for A in codon 234 in exon 7 ( Fig. 7 ). The DU145 cell line has a point mutation, on one allele, in codon 274 with a Dupl, duplication; M, mutation.
transversion from G to T, whereas CNE-1 and CNE-2 cell lines had the identical mutation at codon 280 with a transversion from G to C (Table 3 ; Fig. 6 ).
Sequence C. migration detected on SSCP were completely sequenced through exons 5, 6, 7, and 8 ( Table 2) . Wild-type sequence was present in all samples that had been classified as normal according to the results obtained by SSCP analysis. Sequence analysis of mixtures of mutant and normal DNA in the same sample could detect mutations in the sequencing reactions with 20% mutant DNA (data not shown).
The sequence analyses of the NPC specimens revealed that the samples with abnormal banding patterns all contained mutant sequence. Those DNAs with identical migration by SSCP had identical sequence changes ( Fig. 3 and 6) . Furthermore, it was confirmed that SSCP adequately predicted whether a specimen contained the mutant allele only or whether both a mutant and a wild-type allele were present. Samples displaying both the normal and abnormal banding pattern by SSCP were found to contain the wild type in addition to the mutant sequence, as in the DU145 cell line and exon 7 of NM6 ( Fig. 5A and B and 6A and C). Although A.
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DISCUSSION
The data presented demonstrate that although p53 mutations do occur in NPC, the mutations were primarily identified in the subset of tumors that have been successfully grown in nude mice. In contrast, in direct clinical specimens 0 of the 18 primary tumors and only 2 obtained from metastatic NPC were found to harbor p53 mutations. The absence of p53 mutations suggests that p53 mutation is not a critical event in the initial transformation of the epithelial cells. It is unknown, however, when exactly p53 mutations occur during the neoplastic process. Data obtained from studies of colon carcinomas suggest that they occur as a late event in the molecular carcinogenesis (15). In breast carcinomas p53 mutations do develop in both primary and metastatic disease (9) . However, the absence of mutation in p53
indicates that the genetic and environmental factors which contribute to the development of NPC are not manifested in p53 mutations.
In all the NPC specimens passaged in nude mice with identify the rare NPC with mutant p53. It is also possible that p53 mutation may develop during passage in nude mice. This would suggest that loss of p53 function in NPC provides a growth advantage in nude mice but apparently not in vivo.
Interestingly, cervical cancer is a malignancy which is also associated with viral infection with detection of HPV in the majority of cervical carcinomas (3, 39) . In HPV-associated cervical cancer, mutations in p53 have not been identified, presumably because the p53 gene product is inactivated through the E6 viral gene product (38, 43) . In contrast, mutations in p53 have been detected in HPV-negative cervical cancers (8) . These data suggest that p53 may be involved in cervical carcinoma and can be inactivated either by somatic mutation in p53 or by interaction with the E6 gene product.
The absence of p53 mutations in most NPC may indicate interference by EBV infection with some aspect of p53 function. If p53 function is inactivated by an epigenetic process, selection for cells with a mutation in p53 would not be necessary. In all NPC in which a single EBV-infected cellular clone has predominated, the absence of p53 muta- tions suggests such a lack of selection. grown in nude mice would then reflect a r of p53 function.
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